Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures

NCT05473442 is registered in ClinicalTrials.gov with Equilibre Biopharmaceuticals B.V. as lead sponsor.

NCT NCT05473442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05473442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures
Lead sponsor
Equilibre Biopharmaceuticals B.V.
Phase
Phase 2
Overall status
Terminated
Start date
December 27, 2022
Completion date
July 1, 2023
Enrollment
27 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

focal onset seizures